Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FDM49
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $741,740
Award facts
- Contract value 100% obligated
- $741,739.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $741,739.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Entyvio 300 mg vials. The award, issued on September 29, 2025, with an ultimate completion date of October 21, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at $499,999,999 and extends through November 2026, enabling the agency to procure a comprehensive range of pharmaceutical products supporting medical supply needs across military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts for branded and generic prescription drugs, biologics, and medical consumables. The company's portfolio includes delivery orders for specialized pharmaceutical products ranging from oncology treatments to vaccines and auto-injectors. This particular award for Entyvio 300 mg vials—a biologic medication—reflects the contractor's ongoing role in providing essential pharmaceutical supplies to Department of Defense healthcare sites. The firm's registration in SAM.gov since 2001 and demonstrated track record of federal contracting underscore its position as a reliable vendor for federal pharmaceutical procurement.
Quick answers
Who was awarded contract SPE2DB25FDM49?
SPE2DB25FDM49 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FDM49 worth?
The government has obligated $741,740 on SPE2DB25FDM49.
Is contract SPE2DB25FDM49 an order under another contract?
Yes. SPE2DB25FDM49 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDM49 competed?
The extent of competition for SPE2DB25FDM49 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award